The first Dexcom trade was made in Q2 2010.
Since then George Soros bought shares eight more times and sold shares on twelve occasions. The investor sold all their shares in Q3 2024 and doesn't own any shares in Dexcom anymore.
Avg closing price
Price range
Sold -167 Thousand shares
Q3 2024
Avg closing price
$82.36
Price range
$64.00
-
$116.06
Increased shares by 233.6% (+117 Thousand shares)
Q2 2024
Avg closing price
$126.43
Price range
$110.31
-
$140.45
Sold 54.5% shares (-60 Thousand shares)
Q1 2024
Avg closing price
$125.70
Price range
$114.22
-
$140.10
Sold 40.5% shares (-75 Thousand shares)
Q4 2023
Avg closing price
$102.16
Price range
$75.49
-
$124.16
New holding (+185 Thousand shares)
Q3 2023
Avg closing price
$112.73
Price range
$86.06
-
$137.93
Sold -15.2 Thousand shares
Q1 2018
Avg closing price
$14.79
Price range
$13.06
-
$18.54
New holding (+15.2 Thousand shares)
Q4 2017
Avg closing price
$13.00
Price range
$11.12
-
$15.38
Sold -11.2 Thousand shares
Q2 2017
Avg closing price
$18.47
Price range
$16.71
-
$20.99
Sold 47.2% shares (-10 Thousand shares)
Q1 2017
Avg closing price
$19.52
Price range
$14.56
-
$21.37
Increased shares by 105.7% (+10.9 Thousand shares)
Q4 2016